12:00 AM
Nov 12, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Theliatinib: Phase I started

Hutchison's Hutchison MediPharma Ltd. majority-owned subsidiary began a Chinese Phase I trial to evaluate single and repeat doses of oral theliatinib...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >